KFx Medical
W. Tate Scott, President & CEO

Mr. Scott has a broad career with multinationals Johnson and Johnson and American Hospital Supply involving management positions in marketing, operations, sales, and business development.  As president of Luther Medical Products (NASDAQ:LUTH), he introduced and later sold to Johnson and Johnson the first IV catheter designed to self-sheath and protect health care workers from infectious diseases.  At Johnson and Johnson’s Ethicon Endo Surgery Company Mr. Scott led business development for the general surgery franchise. As Executive Chairman of Orquest Mr. Scott lead the team in the company’s sale for more than $85m to Johnson and Johnson Orthopedics.  At KFx Medical, where Mr. Scott is president and CEO, he led the litigation team in KFx Inc. v. Arthrex, Inc.  The jury in that case awarded KFx in excess of $35m, one of the 10th largest awards in devices in 2014.  The litigation team prevailed as the case was appealed until the Supreme Court denied review of the case.  The legal team continued to prevail versus Arthrex in two IPR’s, a Markman Hearing and settlement.  Presently the team is managing a patent litigation suit versus Stryker.  Mr. Scott has negotiated multiple licensing agreements with Smith & Nephew, Johnson and Johnson, Conmed, Biomet, and Wright Medical which have provided in excess of $50m for shareholders.   Mr. Scott has served or is serving on the boards of: Orquest, Benvenue, Scott Labs, Grace Clinic, and Verikul.  Mr. Scott was awarded his AB and MBA at Duke University where he served on the Alumni Counsel.